DNAVision SA
2.0 FTEThe score of DNAVision shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Total assets -57 % Headcount (avg FTE) -57 %
Accounts of the company itself (not consolidated).
The full file covers 20 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
DNAVision's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | −73,752 € | ||||
| Equity | −879,841 € | ||||
| Cash | 19,451 € | ||||
| EBITDA | −72,117 € | ||||
| Total assets | 27,822 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 21 Sep 2026
- Year ended 31 Dec 2024filed on 19 Sep 2025
- Year ended 31 Dec 2023filed on 29 Aug 2024
- Year ended 31 Dec 2022filed on 31 Aug 2023
- Year ended 31 Dec 2021filed on 13 Oct 2022
DNAVision's financial analysis
- Solvency-3162.3%sector median: 58.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of DNAVision
DNAVision's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0865.300.475
- VAT number
- BE0865300475
- Peppol
- Registered · 0208:0865300475 · as of 02 Nov 2026
- Legal form
- SA
- Incorporated
- 13 May 2004
- Registered office
- 6041 Charleroi
- Size
- Micro · 2.0 FTE
- Latest accounts
- 2025 · filed on 21 Sep 2026
- Activity
- Research and experimental development on biotechnology (NACE 72101)
DNAVision (SA) has been based in Charleroi since 2004, active in: research and experimental development on biotechnology. For 2025, it reports a net loss of 73,752 € and equity of −879,841 €; its revenue is not published. With 2.0 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at -3162.3%, below the median of its sector (58.2%).
Companies similar to DNAVision
Companies in the same business, of comparable size and area, outside its group.
- Baxter R and D Europe Research and experimental development on natural sciences and engineering Lessines · balance sheet €52.7m
- Lakefront Biotherapeutics Research and experimental development on natural sciences and engineering Mechelen · balance sheet €3.34bn
- NovelYeast Research and experimental development on natural sciences and engineering Oud-Heverlee · balance sheet 968,333 €
- Omega Pharma Innovation & Development Research and experimental development on natural sciences and engineering Ghent · balance sheet €246.6m
- SanaClis Research and experimental development on natural sciences and engineering Diepenbeek · balance sheet 46,543 €
- CTI Clinical Trial and Consulting Services Belgium Research and experimental development on natural sciences and engineering Woluwe-Saint-Pierre · balance sheet 659,954 €
- IDRO Research and experimental development on natural sciences and engineering Antwerp · balance sheet 234,400 €
- IPM Impact Research and experimental development on natural sciences and engineering Hasselt · balance sheet 315,364 €
Frequently asked questions about DNAVision
What is the revenue of DNAVision?
DNAVision files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of DNAVision?
In Belgium, the VAT number is the company number prefixed with BE: BE0865300475 for DNAVision, if the company is VAT-registered. Its company number (CBE) is 0865.300.475.
Where is the registered office of DNAVision?
According to the CBE register, the registered office of DNAVision is in 6041 Charleroi.
What is the equity of DNAVision?
At the close of the 2025 financial year, the equity of DNAVision amounts to -879,841 €, a solvency of -3162.3% of total assets.
How many people work at DNAVision?
2.0 full-time equivalents on average according to the 2025 social balance sheet.
Who manages DNAVision?
The register lists 6 active mandates at DNAVision. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of DNAVision
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →